SCHEDULE: Cadian Capital Discloses 4.9% Stake in Tactile Systems
Beneficial Ownership Disclosure
Cadian Capital Management and its affiliates reported a 4.9% beneficial ownership stake in Tactile Systems Technology Inc. as of December 31, 2025.
Summary
- Cadian Capital Management, LP, Cadian Capital Management GP, LLC, and Eric Bannasch (collectively, the "Reporting Persons") beneficially own 1,084,094 shares of Tactile Systems Technology Inc. Common Stock.
- This represents approximately 4.9% of the Issuer's outstanding Common Stock, based on 22,335,582 shares outstanding as of October 30, 2025.
- The shares are held by Cadian Master Fund L.P. and Cadian Opportunities Master Fund LP, advisory clients of Cadian Capital Management, LP.
- The Reporting Persons exercise shared voting and dispositive power over these shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of beneficial ownership by an institutional investor and does not contain new operational or financial information about the issuer.
Positives
- A significant institutional investor, Cadian Capital Management, maintains a substantial stake in Tactile Systems Technology Inc., indicating continued interest.
Negatives
- No specific negative information regarding Tactile Systems Technology Inc. is disclosed in this beneficial ownership filing.
Risks
- No specific risks related to Tactile Systems Technology Inc. are mentioned in this beneficial ownership filing.
Future Outlook
Not applicable as this filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the issuer.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures by passive investors holding less than 5% of a company's stock, or institutional investors holding more than 5% but without intent to influence control. This filing indicates Cadian Capital Management's continued passive investment in the medical technology sector, specifically in Tactile Systems Technology, which operates in the lymphedema and chronic venous insufficiency treatment market.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, confirming a major investor's continued stake.
Key Dates
| Date | Description |
|---|---|
| 2025-10-30 | Date of outstanding shares calculation (22,335,582 shares) as disclosed in Issuer's Form 10-Q. |
| 2025-12-31 | Date of event which requires filing of this statement, reflecting the beneficial ownership stake. |
| 2026-02-17 | Filing date of the Schedule 13G Amendment No. 3. |
Keywords
Tactile Systems Technology, Cadian Capital Management, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, TRHC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.